| Literature DB >> 34223001 |
Cherh Yun Teoh1, Adliah Mhd Ali1, Noraida Mohamed Shah1, Rohana Hassan2, Chee Lan Lau3.
Abstract
BACKGROUND: There is a paucity of data on pharmacists' competency and learning needs in antimicrobial stewardship (AMS).Entities:
Year: 2020 PMID: 34223001 PMCID: PMC8210314 DOI: 10.1093/jacamr/dlaa035
Source DB: PubMed Journal: JAC Antimicrob Resist ISSN: 2632-1823
Demographic characteristics of the respondents (N = 553)
| Characteristics | Received prior specific training on infections and AMS ( | Did not receive prior specific training on infections and AMS ( |
| ||
|---|---|---|---|---|---|
| frequency, | % | frequency, | % | ||
| Gender | |||||
| male | 22 | 4.0 | 67 | 12.1 | 0.837 (0.042) |
| female | 110 | 19.9 | 354 | 64.0 | |
| Age (years) | |||||
| 20–29 | 37 | 6.7 | 171 | 30.9 | <0.001 (29.897) |
| 30–39 | 86 | 15.6 | 249 | 45.0 | |
| ≥40 | 9 | 1.6 | 1 | 0.2 | |
| Highest academic qualification | |||||
| Bachelor’s degree | 95 | 17.2 | 333 | 60.2 | 0.088 (2.918) |
| Master’s degree and above | 37 | 6.7 | 88 | 15.9 | |
| Hospital settings | |||||
| main state hospital, university hospital and special medical institution | 67 | 12.1 | 197 | 35.6 | 0.752 (1.203) |
| major specialist hospital | 45 | 8.1 | 161 | 29.1 | |
| minor specialist hospital | 19 | 3.4 | 57 | 10.3 | |
| non-specialist hospital | 1 | 0.2 | 6 | 1.1 | |
| Discipline of practice | |||||
| general medical | 45 | 8.1 | 164 | 29.7 | 0.241 (2.846) |
| infectious disease | 5 | 0.9 | 7 | 1.3 | |
| others | 82 | 14.8 | 250 | 45.2 | |
| Duration as a ward pharmacist (years) | |||||
| <1 | 3 | 0.5 | 44 | 8.0 | <0.001 (34.175) |
| 1–5 | 63 | 11.4 | 269 | 48.6 | |
| 6–10 | 54 | 9.8 | 97 | 17.5 | |
| >10 | 12 | 2.2 | 11 | 2.0 | |
Summary of self-perceived competence in AMS among government ward pharmacists in Malaysia (N = 553)
| Variables | Number of respondents, | Mean score | Median score | ||||
|---|---|---|---|---|---|---|---|
| I know nothing | I know a little | I know an adequate amount | I know a lot | I am an expert | |||
| All types of infections and comorbidities including: | |||||||
| aetiology | 12 (2.2) | 216 (39.1) | 302 (54.6) | 21 (3.8) | 2 (0.4) | 2.61 | 3.00 |
| physiology | 7 (1.3) | 247 (44.7) | 272 (49.2) | 24 (4.3) | 3 (0.5) | 2.58 | 3.00 |
| common signs and symptoms | 2 (0.4) | 156 (28.2) | 335 (60.6) | 55 (9.9) | 5 (0.9) | 2.82 | 3.00 |
| epidemiology | 33 (6.0) | 275 (49.7) | 230 (41.6) | 13 (2.4) | 2 (0.4) | 2.41 | 2.00 |
| risk factors | 5 (0.9) | 182 (32.9) | 316 (57.1) | 46 (8.3) | 4 (0.7) | 2.75 | 3.00 |
| Details of antimicrobials including: | |||||||
| mechanism of action | 1 (0.2) | 135 (24.4) | 357 (64.6) | 54 (9.8) | 6 (1.1) | 2.87 | 3.00 |
| indications | 1 (0.2) | 61 (11.0) | 367 (66.4) | 115 (20.8) | 9 (1.6) | 3.13 | 3.00 |
| adverse effects and precautions | 1 (0.2) | 110 (19.9) | 367 (66.4) | 71 (12.8) | 4 (0.7) | 2.94 | 3.00 |
| drug interactions | 5 (0.9) | 177 (32.0) | 321 (58.0) | 47 (8.5) | 3 (0.5) | 2.76 | 3.00 |
| off-label use of drugs | 23 (4.2) | 299 (54.1) | 202 (36.5) | 27 (4.9) | 2 (0.4) | 2.43 | 2.00 |
| Therapeutic management of patients with infections | 2 (0.4) | 87 (15.7) | 379 (68.5) | 80 (14.5) | 5 (0.9) | 3.00 | 3.00 |
| Policies, procedures and treatment guidelines | 3 (0.5) | 117 (21.2) | 358 (64.7) | 69 (12.5) | 6 (1.1) | 2.92 | 3.00 |
| Interpretation of lab tests and/or disease markers | 3 (0.5) | 102 (18.4) | 362 (65.5) | 81 (14.6) | 5 (0.9) | 2.97 | 3.00 |
| System of the antimicrobial stewardship service |
14 (2.5) |
156 (28.2) |
284 (51.4) |
94 (17.0) |
5 (0.9) | 2.86 | 3.00 |
|
Not confident at all |
Not very confident |
Somewhat confident |
Very confident |
Extremely confident | |||
| Identify and manage patients with complex pharmaceutical care issues | 6 (1.1) | 124 (22.4) | 341 (61.7) | 77 (13.9) | 5 (0.9) | 2.91 | 3.00 |
| Recommend appropriate monitoring parameters | 2 (0.4) | 69 (12.5) | 357 (64.6) | 118 (21.3) | 7 (1.3) | 3.11 | 3.00 |
| Advise on pharmacokinetic and pharmacodynamic principles of antimicrobials | 11 (2.0) | 139 (25.1) | 300 (54.2) | 92 (16.6) | 11 (2.0) | 2.92 | 3.00 |
| Advise on antimicrobial optimization | 4 (0.7) | 104 (18.8) | 309 (55.9) | 126 (22.8) | 10 (1.8) | 3.06 | 3.00 |
| Advise on relevant policies and procedures in antimicrobial stewardship | 18 (3.3) | 170 (30.7) | 275 (49.7) | 81 (14.6) | 9 (1.6) | 2.81 | 3.00 |
| Advise on relevant pharmacoeconomic issues relating to antimicrobials | 46 (8.3) | 235 (42.5) | 222 (40.1) | 45 (8.1) | 5 (0.9) | 2.51 | 2.00 |
| Support other staff in aspects of pharmaceutical and related care of patients with infections | 6 (1.1) | 102 (18.4) | 321 (58.0) | 113 (20.4) | 11 (2.0) | 3.04 | 3.00 |
| Make an informed decision timely, based on analysed evidence, with the ability to defend your decisions accordingly |
5 (0.9) |
125 (22.6) |
330 (59.7) |
85 (15.4) |
8 (1.4) | 2.94 | 3.00 |
|
Strongly disagree |
Disagree |
Neither agree or disagree |
Agree |
Strongly agree | |||
| I am able to consider/take into account various factors and situations while making clinical judgement pertaining to antimicrobial pharmacotherapy | 3 (0.5) | 10 (1.8) | 123 (22.2) | 388 (70.2) | 29 (5.2) | 3.78 | 4.00 |
| I am not able to work in the absence of senior’s support | 77 (13.9) | 277 (50.1) | 140 (25.3) | 55 (9.9) | 4 (0.7) | 3.67 | 4.00 |
| I am not able to recognize my own limitations and refer appropriately to others within and outside own team |
90 (16.3) |
295 (53.3) |
116 (21.0) |
48 (8.7) |
4 (0.7) | 3.76 | 4.00 |
|
Never |
Rarely |
Sometimes |
Often |
Always | |||
| Apply organization policies, procedures and guidance related to local and national antimicrobial pharmacy service | 28 (5.1) | 36 (6.5) | 156 (28.2) | 230 (41.6) | 103 (18.6) | 3.62 | 4.00 |
| Initiate or participate in planning or implementation of clinical audit and evaluation of the antimicrobial pharmacy service | 92 (16.6) | 127 (23.0) | 176 (31.8) | 110 (19.9) | 48 (8.7) | 2.81 | 3.00 |
| Provide advice to other healthcare professionals on various situations pertaining to antimicrobial use | 9 (1.6) | 46 (8.3) | 193 (34.9) | 214 (38.7) | 91 (16.5) | 3.60 | 4.00 |
Multiple linear regression analysis to identify predictors of self-perceived competence in AMS among government ward pharmacists in Malaysia (N = 553)
| Variable | β unstandardized coefficients | Standard error | β standardized coefficients |
|
| 95% CI for β |
|
| |
|---|---|---|---|---|---|---|---|---|---|
| lower bound | upper bound | ||||||||
| Constant | 86.152 | 1.720 | 50.080 | <0.001 | 82.773 | 89.531 | 0.194 | 14.487 ( | |
| Female gender | −6.786 | 1.376 | −0.190 | −4.932 | <0.001 | −9.488 | −4.083 | ||
| Master’s degree and above | 5.718 | 1.311 | 0.183 | 4.360 | <0.001 | 3.142 | 8.294 | ||
| Major specialist hospitals | 0.172 | 1.109 | 0.006 | 0.155 | 0.877 | −2.007 | 2.352 | ||
| Minor specialist hospitals | −2.844 | 1.613 | −0.075 | −1.763 | 0.078 | −6.013 | 0.324 | ||
| Non-specialist hospitals | −5.509 | 4.619 | −0.047 | −1.193 | 0.233 | −14.582 | 3.563 | ||
| Discipline of practice in infectious disease | 7.416 | 3.608 | 0.083 | 2.055 | <0.05 | 0.328 | 14.504 | ||
| Other discipline of practice | −1.712 | 1.092 | −0.064 | −1.567 | 0.118 | −3.858 | 0.434 | ||
| Prior specific training in infections and AMS | 5.931 | 1.220 | 0.193 | 4.863 | <0.001 | 3.535 | 8.328 | ||
| Duration of working experience as a ward pharmacist | 0.567 | 0.176 | 0.143 | 3.226 | <0.005 | 0.222 | 0.913 | ||